Scrip's Stock Tracker: Another volatile month in June
This article was originally published in Scrip
When will this roller coaster ride end? Scrip's Stock Tracker described May as a month of continued uncertainty in the world’s capital markets, and the picture remained volatile in June as well. The end of the month gives a chance to review performance in June, as well as the first half of 2008, with a particular focus on the 10 global pharma and five US biotech stocks tracked each month by Scrip. Independent consultant Emma Palmer reviews the month.
You may also be interested in...
Laura Soucek, one of In Vivo’s 2020 Rising Leaders, is hoping to take Barcelona-based start-up Peptomyc to the next level. The company is nearing the clinic with an inhibitor of the transcription factor Myc, which is involved in the regulation of cellular proliferation, but can also be a driver of cancer.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
With a candidate COVID-19 therapy in clinical development, the UK’s Synairgen has raised $101m on the UK’s AIM to support clinical studies and manufacturing plans.